Evaluation of the neuropharmacological effects of Gardenin A in mice
- PMID: 32181517
- DOI: 10.1002/ddr.21659
Evaluation of the neuropharmacological effects of Gardenin A in mice
Abstract
This work describes the neuropharmacological (sedative, anxiolytic, antidepressant, and anticonvulsant) actions of Gardenin A (GA) (0.1-25 mg/kg p.o.), a flavonoid found in medicinal plants. The sedative effects of GA were assessed with the pentobarbital-induced sleep test. The anxiolytic actions of GA were evaluated with the elevated plus-maze, the light-dark box test, the exploratory cylinder assay, and the open field test. Motor coordination was evaluated with the rotarod test and the open field test. The antidepressant-like actions of GA were evaluated with the tail suspension test and forced swimming test. The mechanisms of the anxiolytic-like and antidepressant-like effects of GA were assessed using inhibitors of neurotransmission pathways. The anticonvulsant activity of GA was evaluated with the strychnine-induced seizure test. The sedative effects of GA were evident only at a dose of 25 mg/kg, which increased the duration of sleep but did not alter sleep onset. GA showed anxiolytic-like actions with activity comparable to that of clonazepam in all experimental tests. The GABAA receptor antagonist bicuculline reversed the anxiolytic-like effects of GA. Furthermore, GA showed significant antidepressant-like actions in both models with activity comparable to that of fluoxetine. Yohimbine, an α2-adrenoceptor blocker, inhibited the antidepressant-like actions of GA. In addition, GA (1-10 mg/kg) did not affect locomotor coordination in mice and delayed the onset of convulsions. These findings suggest that GA induces anxiolytic-like effects and has anticonvulsant actions by the possible involvement of the GABAergic system. The antidepressant-like actions of GA may be mediated by noradrenergic neurotransmission.
Keywords: Gardenin a; anxiety; convulsion; depression; sedative.
© 2020 Wiley Periodicals, Inc.
References
REFERENCES
-
- Abdallah, H. M., Zakaria, E. M., El-Halawany, A. M., Mohamed, G. A., Safo, M. K., & El-Bassossy, H. M. (2019). Psiadia punctulata major flavonoids alleviate exaggerated vasoconstriction produced by advanced glycation end products. PLoS One, 14(9), e0222101.
-
- Bilkei-Gorzo, A., Racz, I., Michel, K., & Zimmer, A. (2002). Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene. Journal of Neuroscience, 22(22), 10046-10052.
-
- Cai, R. J., Wei, J., Jing, F. L., Zhao, G. Z., & Zhang, Y. (2017). Identification of metabolites of gardenin a in rat liver microsomes using ultra-high performance liquid chromatography coupled with linear ion-trap orbitrap mass spectrometry. Tropical Journal of Pharmaceutical Research, 16(2), 421-427.
-
- Domschke, K., & Zwanzger, P. (2008). GABAergic and endocannabinoid dysfunction in anxiety - Future therapeutic targets? Current Pharmaceutical Design, 14(33), 3508-3517.
-
- Fujimori, H. (1965). Potentiation of barbital hypnosis as an evaluation method for central nervous system depressants. Psychopharmacologia, 7(5), 374-378.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical